Llwytho...
Incorporation of RG1 epitope into HPV16L1-VLP does not compromise L1-specific immunity
The candidate pan-Human Papillomavirus (HPV) vaccine RG1-VLP are HPV16 major capsid protein L1 virus-like-particles (VLP) comprising a type-common epitope of HPV16 minor capsid protein L2 (RG1; aa17–36). Vaccinations have previously demonstrated efficacy against genital high-risk (hr), low-risk (lr)...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Vaccine |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6832690/ https://ncbi.nlm.nih.gov/pubmed/31147274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2019.05.011 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|